115 related articles for article (PubMed ID: 3385278)
21. [Evaluation of surgical resection of pulmonary metastasis of trophoblastic tumour].
Ren T; Xiang Y; Yang XY; Wan XR; Zhang ZY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Aug; 25(4):418-21. PubMed ID: 12974086
[TBL] [Abstract][Full Text] [Related]
22. Low-risk gestational trophoblastic neoplasia and methotrexate resistance: predictors of response to treatment with actinomycin D and need for combination chemotherapy.
Growdon WB; Wolfberg AJ; Goldstein DP; Feltmate CM; Chinchilla ME; Lieberman ES; Berkowitz RS
J Reprod Med; 2010; 55(7-8):279-84. PubMed ID: 20795339
[TBL] [Abstract][Full Text] [Related]
23. The management of gestational trophoblastic tumors with etoposide, methotrexate, and actinomycin D.
Soto-Wright V; Goldstein DP; Bernstein MR; Berkowitz RS
Gynecol Oncol; 1997 Jan; 64(1):156-9. PubMed ID: 8995566
[TBL] [Abstract][Full Text] [Related]
24. "Poor prognosis" metastatic gestational trophoblastic disease: the prognostic significance of the scoring system in predicting chemotherapy failures.
Mortakis AE; Braga CA
Obstet Gynecol; 1990 Aug; 76(2):272-7. PubMed ID: 2164651
[TBL] [Abstract][Full Text] [Related]
25. Persistent gestational trophoblastic disease: results of MEA (methotrexate, etoposide and dactinomycin) as first-line chemotherapy in high risk disease and EA (etoposide and dactinomycin) as second-line therapy for low risk disease.
Dobson LS; Lorigan PC; Coleman RE; Hancock BW
Br J Cancer; 2000 May; 82(9):1547-52. PubMed ID: 10789722
[TBL] [Abstract][Full Text] [Related]
26. Term delivery following successful treatment of choriocarcinoma with brain metastases, a case report and review of literature.
Behtash N; Behnamfar F; Hamedi B; Ramezanzadeh F
Arch Gynecol Obstet; 2009 Apr; 279(4):579-81. PubMed ID: 18726607
[TBL] [Abstract][Full Text] [Related]
27. Salvage chemotherapy with methotrexate, etoposide and actinomycin D in men with metastatic nonseminomatous germ cell tumors with a choriocarcinoma component: a preliminary report.
Terakawa T; Miyake H; Muramaki M; Takenaka A; Fujisawa M
Int J Urol; 2010 Oct; 17(10):881-5. PubMed ID: 20731738
[TBL] [Abstract][Full Text] [Related]
28. Secondary chemotherapy for high-risk gestational trophoblastic neoplasia.
Lurain JR; Nejad B
Gynecol Oncol; 2005 May; 97(2):618-23. PubMed ID: 15863169
[TBL] [Abstract][Full Text] [Related]
29. [Multidisciplinary treatment of choriocarcinoma].
Tomoda Y; Kaseki S; Goto S; Ishizuka T; Nishikawa Y; Hattori S; Furuhashi Y; Kato S; Mano H
Gan No Rinsho; 1985 Jul; 31(9 Suppl):1160-4. PubMed ID: 3840542
[TBL] [Abstract][Full Text] [Related]
30. Etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine for the treatment of metastatic, high-risk gestational trophoblastic disease.
Schink JC; Singh DK; Rademaker AW; Miller DS; Lurain JR
Obstet Gynecol; 1992 Nov; 80(5):817-20. PubMed ID: 1328977
[TBL] [Abstract][Full Text] [Related]
31. [A case of complete remission obtained with etoposide in uterine choriocarcinoma].
Kikuchi J; Sasaki T; Ishibashi K; Takaya R; Mori H; Endo H; Shima I; Moritsuka T; Takahashi K
Gan To Kagaku Ryoho; 1991 Jun; 18(7):1209-12. PubMed ID: 2053779
[TBL] [Abstract][Full Text] [Related]
32. Uterine choriocarcinoma accompanied by an extremely high human chorionic gonadotropin level and thyrotoxicosis.
Hsieh TY; Hsu KF; Kuo PL; Huang SC
J Obstet Gynaecol Res; 2008 Apr; 34(2):274-8. PubMed ID: 18412797
[TBL] [Abstract][Full Text] [Related]
33. Long-term remission of previously resistant choriocarcinoma with a combination of etoposide, ifosfamide, and cisplatin.
Garris PD; Gallup DG; Melton K
Gynecol Oncol; 1995 May; 57(2):254-6. PubMed ID: 7729745
[TBL] [Abstract][Full Text] [Related]
34. [Combination chemotherapy of 5-fluorouracil and nitrocaphane for the treatment of malignant trophoblastic tumor].
Ju L; Wang Y; Qu D
Zhonghua Fu Chan Ke Za Zhi; 1996 Apr; 31(4):212-5. PubMed ID: 8758775
[TBL] [Abstract][Full Text] [Related]
35. [Methotrexate in gynecologic oncology].
Isonishi S; Terashima Y
Gan To Kagaku Ryoho; 1996 Dec; 23(14):1896-900. PubMed ID: 8978793
[TBL] [Abstract][Full Text] [Related]
36. A novel strategy using G-CSF to support EMA/CO for high-risk gestational trophoblastic disease.
Hartenbach EM; Saltzman AK; Carter JR; Twiggs LB
Gynecol Oncol; 1995 Jan; 56(1):105-8. PubMed ID: 7529741
[TBL] [Abstract][Full Text] [Related]
37. Gestational choriocarcinoma: morphological features in a liquid-based endometrial cytological sample.
Garbini F; Buccoliero AM; Castiglione F; Gheri CF; Moncini D; Rossi Degl'Innocenti D; Barbetti A; Villanucci A; Taddei GL
Diagn Cytopathol; 2008 Feb; 36(2):113-4. PubMed ID: 18181184
[No Abstract] [Full Text] [Related]
38. Management of drug resistant gestational trophoblastic neoplasia.
Patel SM; Desai A
J Reprod Med; 2010; 55(7-8):296-300. PubMed ID: 20795341
[TBL] [Abstract][Full Text] [Related]
39. Relapse rate of patients with low-risk gestational trophoblastic tumor initially treated with single-agent chemotherapy.
Matsui H; Suzuka K; Yamazawa K; Tanaka N; Mitsuhashi A; Seki K; Sekiya S
Gynecol Oncol; 2005 Mar; 96(3):616-20. PubMed ID: 15721402
[TBL] [Abstract][Full Text] [Related]
40. Management of high-risk hydatidiform mole and persistent gestational trophoblastic neoplasia: the Korean experience.
Kim SJ; Na YJ; Jung SG; Kim CJ; Bae SN; Lee C
J Reprod Med; 2007 Sep; 52(9):819-30. PubMed ID: 17939600
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
